ID   RAN_HUMAN               Reviewed;         216 AA.
AC   P62826; A8K3Z8; P17080; P28746; P28747; Q6IPB2; Q86V08; Q8NI90;
AC   Q9CSP3; Q9CWI7; Q9CZA2; Q9UDJ5; Q9UEU9;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-JUL-2015, entry version 148.
DE   RecName: Full=GTP-binding nuclear protein Ran;
DE   AltName: Full=Androgen receptor-associated protein 24;
DE   AltName: Full=GTPase Ran;
DE   AltName: Full=Ras-like protein TC4;
DE   AltName: Full=Ras-related nuclear protein;
GN   Name=RAN; Synonyms=ARA24; ORFNames=OK/SW-cl.81;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=2108320;
RA   Drivas G.T., Shih A., Coutavas E., Rush M.G., D'Eustachio P.;
RT   "Characterization of four novel ras-like genes expressed in a human
RT   teratocarcinoma cell line.";
RL   Mol. Cell. Biol. 10:1793-1798(1990).
RN   [2]
RP   SEQUENCE REVISION TO C-TERMINUS.
RX   PubMed=1855255; DOI=10.1016/0092-8674(91)90624-8;
RA   Matsumoto T., Beach D.H.;
RT   "Premature initiation of mitosis in yeast lacking RCC1 or an
RT   interacting GTPase.";
RL   Cell 66:347-360(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-19 AND GLN-69.
RC   TISSUE=Brain;
RX   PubMed=8421051; DOI=10.1083/jcb.120.2.313;
RA   Ren M., Drivas G.T., D'Eustachio P., Rush M.G.;
RT   "Ran/TC4: a small nuclear GTP-binding protein that regulates DNA
RT   synthesis.";
RL   J. Cell Biol. 120:313-323(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH AR, AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=10400640; DOI=10.1074/jbc.274.29.20229;
RA   Hsiao P.-W., Lin D.-L., Nakao R., Chang C.;
RT   "The linkage of Kennedy's neuron disease to ARA24, the first
RT   identified androgen receptor polyglutamine region-associated
RT   coactivator.";
RL   J. Biol. Chem. 274:20229-20234(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph, Ovary, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 2-23 AND 143-166, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (FEB-2006) to UniProtKB.
RN   [13]
RP   PROTEIN SEQUENCE OF 39-56 AND 153-166, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 65-216.
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-
RT   reactive CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   PROTEIN SEQUENCE OF 65-76; 90-125; 128-147 AND 154-216, INTERACTION
RP   WITH CHC1, AND SUBCELLULAR LOCATION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=1961752; DOI=10.1073/pnas.88.23.10830;
RA   Bischoff F.R., Ponstingl H.;
RT   "Mitotic regulator protein RCC1 is complexed with a nuclear ras-
RT   related polypeptide.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:10830-10834(1991).
RN   [16]
RP   FUNCTION.
RX   PubMed=8692944; DOI=10.1073/pnas.93.14.7059;
RA   Moroianu J., Blobel G., Radu A.;
RT   "Nuclear protein import: Ran-GTP dissociates the karyopherin alphabeta
RT   heterodimer by displacing alpha from an overlapping binding site on
RT   beta.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:7059-7062(1996).
RN   [17]
RP   IDENTIFICATION IN A NUCLEAR EXPORT COMPLEX WITH XPO1.
RX   PubMed=9323133; DOI=10.1016/S0092-8674(00)80371-2;
RA   Fornerod M., Ohno M., Yoshida M., Mattaj I.W.;
RT   "CRM1 is an export receptor for leucine-rich nuclear export signals.";
RL   Cell 90:1051-1060(1997).
RN   [18]
RP   IDENTIFICATION IN A COMPLEX WITH HIV-1 REV; HIV-1 REV RESPONSE ELEMENT
RP   AND XPO1.
RX   PubMed=9837918; DOI=10.1074/jbc.273.50.33414;
RA   Askjaer P., Jensen T.H., Nilsson J., Englmeier L., Kjems J.;
RT   "The specificity of the CRM1-Rev nuclear export signal interaction is
RT   mediated by RanGTP.";
RL   J. Biol. Chem. 273:33414-33422(1998).
RN   [19]
RP   IDENTIFICATION IN A NUCLEAR EXPORT RECEPTOR COMPLEX, AND
RP   IDENTIFICATION IN A TRIMERIC EXPORT COMPLEX WITH SNUPN AND XPO1.
RX   PubMed=10209022; DOI=10.1083/jcb.145.2.255;
RA   Paraskeva E., Izaurralde E., Bischoff F.R., Huber J., Kutay U.,
RA   Hartmann E., Luehrmann R., Goerlich D.;
RT   "CRM1-mediated recycling of snurportin 1 to the cytoplasm.";
RL   J. Cell Biol. 145:255-264(1999).
RN   [20]
RP   IDENTIFICATION IN A NUCLEAR EXPORT COMPLEX WITH RANBP3 AND XPO1.
RX   PubMed=11571268; DOI=10.1093/embo-reports/kve200;
RA   Englmeier L., Fornerod M., Bischoff F.R., Petosa C., Mattaj I.W.,
RA   Kutay U.;
RT   "RanBP3 influences interactions between CRM1 and its nuclear protein
RT   export substrates.";
RL   EMBO Rep. 2:926-932(2001).
RN   [21]
RP   IDENTIFICATION IN A NUCLEAR EXPORT COMPLEX WITH RANBP3 AND XPO1.
RX   PubMed=11425870; DOI=10.1083/jcb.153.7.1391;
RA   Lindsay M.E., Holaska J.M., Welch K., Paschal B.M., Macara I.G.;
RT   "Ran-binding protein 3 is a cofactor for Crm1-mediated nuclear protein
RT   export.";
RL   J. Cell Biol. 153:1391-1402(2001).
RN   [22]
RP   IDENTIFICATION IN A COMPLEX WITH COPS5; RANBP9 AND DYRK1B.
RX   PubMed=14500717; DOI=10.1074/jbc.M307556200;
RA   Zou Y., Lim S., Lee K., Deng X., Friedman E.;
RT   "Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial
RT   cell migration and is negatively regulated by the Met adaptor Ran-
RT   binding protein M.";
RL   J. Biol. Chem. 278:49573-49581(2003).
RN   [23]
RP   INTERACTION WITH TERT.
RX   PubMed=12808100; DOI=10.1128/MCB.23.13.4598-4610.2003;
RA   Haendeler J., Hoffmann J., Brandes R.P., Zeiher A.M., Dimmeler S.;
RT   "Hydrogen peroxide triggers nuclear export of telomerase reverse
RT   transcriptase via Src kinase family-dependent phosphorylation of
RT   tyrosine 707.";
RL   Mol. Cell. Biol. 23:4598-4610(2003).
RN   [24]
RP   IDENTIFICATION IN A COMPLEX WITH HTLV-1 REX; RANBP3 AND XPO1.
RX   PubMed=14612415; DOI=10.1128/MCB.23.23.8751-8761.2003;
RA   Hakata Y., Yamada M., Shida H.;
RT   "A multifunctional domain in human CRM1 (exportin 1) mediates RanBP3
RT   binding and multimerization of human T-cell leukemia virus type 1 Rex
RT   protein.";
RL   Mol. Cell. Biol. 23:8751-8761(2003).
RN   [25]
RP   INTERACTION WITH RANBP9 AND RANBP10.
RX   PubMed=14684163; DOI=10.1016/j.bbrc.2003.11.124;
RA   Wang D., Li Z., Schoen S.R., Messing E.M., Wu G.;
RT   "A novel MET-interacting protein shares high sequence similarity with
RT   RanBPM, but fails to stimulate MET-induced Ras/Erk signaling.";
RL   Biochem. Biophys. Res. Commun. 313:320-326(2004).
RN   [26]
RP   IDENTIFICATION IN A NUCLEAR EXPORT COMPLEX WITH XPO1.
RX   PubMed=15574331; DOI=10.1016/j.molcel.2004.11.018;
RA   Petosa C., Schoehn G., Askjaer P., Bauer U., Moulin M., Steuerwald U.,
RA   Soler-Lopez M., Baudin F., Mattaj I.W., Mueller C.W.;
RT   "Architecture of CRM1/Exportin1 suggests how cooperativity is achieved
RT   during formation of a nuclear export complex.";
RL   Mol. Cell 16:761-775(2004).
RN   [27]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [28]
RP   FUNCTION, INTERACTION WITH BIRC5, AND MUTAGENESIS OF THR-24 AND
RP   GLN-69.
RX   PubMed=18591255; DOI=10.1128/MCB.02039-07;
RA   Xia F., Canovas P.M., Guadagno T.M., Altieri D.C.;
RT   "A survivin-ran complex regulates spindle formation in tumor cells.";
RL   Mol. Cell. Biol. 28:5299-5311(2008).
RN   [29]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH VRK1; VRK2 AND
RP   VRK3.
RX   PubMed=18617507; DOI=10.1074/mcp.M700586-MCP200;
RA   Sanz-Garcia M., Lopez-Sanchez I., Lazo P.A.;
RT   "Proteomics identification of nuclear Ran GTPase as an inhibitor of
RT   human VRK1 and VRK2 (vaccinia-related kinase) activities.";
RL   Mol. Cell. Proteomics 7:2199-2214(2008).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [31]
RP   INTERACTION WITH MAD2L2, AND SUBCELLULAR LOCATION.
RX   PubMed=19753112; DOI=10.1371/journal.pone.0007020;
RA   Medendorp K., van Groningen J.J., Vreede L., Hetterschijt L.,
RA   van den Hurk W.H., de Bruijn D.R., Brugmans L., van Kessel A.G.;
RT   "The mitotic arrest deficient protein MAD2B interacts with the small
RT   GTPase RAN throughout the cell cycle.";
RL   PLoS ONE 4:E7020-E7020(2009).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-60; LYS-71; LYS-99 AND
RP   LYS-159, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [34]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [35]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   PubMed=7885480; DOI=10.1038/374378a0;
RA   Scheffzek K., Klebe C., Fritz-Wolf K., Kabsch W., Wittinghofer A.;
RT   "Crystal structure of the nuclear Ras-related protein Ran in its GDP-
RT   bound form.";
RL   Nature 374:378-381(1995).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF COMPLEX WITH KPNB2.
RX   PubMed=10353245; DOI=10.1038/20375;
RA   Chook Y.M., Blobel G.;
RT   "Structure of the nuclear transport complex karyopherin-beta2-Ran x
RT   GppNHp.";
RL   Nature 399:230-237(1999).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.96 ANGSTROMS) OF COMPLEX WITH NUP358.
RX   PubMed=10078529; DOI=10.1038/17969;
RA   Vetter I.R., Nowak C., Nishimoto T., Kuhlmann J., Wittinghofer A.;
RT   "Structure of a Ran-binding domain complexed with Ran bound to a GTP
RT   analogue: implications for nuclear transport.";
RL   Nature 398:39-46(1999).
CC   -!- FUNCTION: GTP-binding protein involved in nucleocytoplasmic
CC       transport. Required for the import of protein into the nucleus and
CC       also for RNA export. Involved in chromatin condensation and
CC       control of cell cycle (By similarity). The complex with BIRC5/
CC       survivin plays a role in mitotic spindle formation by serving as a
CC       physical scaffold to help deliver the RAN effector molecule TPX2
CC       to microtubules. Acts as a negative regulator of the kinase
CC       activity of VRK1 and VRK2. {ECO:0000250}.
CC   -!- FUNCTION: Enhances AR-mediated transactivation. Transactivation
CC       decreases as the poly-Gln length within AR increases.
CC   -!- SUBUNIT: Monomer. Also forms a complex with CHC1 and interacts
CC       with the AR N-terminal poly-Gln region. The interaction with AR is
CC       inversely correlated with the poly-Gln length. Part of a complex
CC       consisting of RANBP9, Ran, DYRK1B and COPS5. Found in a nuclear
CC       export complex with RANBP3 and XPO1. Component of a nuclear export
CC       receptor complex composed of KPNB1, Ran, SNUPN and XPO1. Found in
CC       a trimeric export complex with SNUPN, Ran and XPO1. Interacts with
CC       RANBP10. In case of HIV-1 infection, found in a complex with HIV-1
CC       Rev, RNAs containing a Rev response element (RRE) and XPO1. Found
CC       in a complex with HTLV-1 Rex, RANBP3 and XPO1. Interacts in its
CC       GTP-bound form with BIRC5/survivin at S and M phases of the cell
CC       cycle. Interacts with TERT; the interaction requires hydrogen
CC       peroxide-mediated phosphorylation of TERT and transports TERT to
CC       the nucleus. Interacts with MAD2L2. Interacts with RANBP10 (By
CC       similarity). Interacts with VRK1 and VRK3. Interacts with isoform
CC       1 and isoform 2 of VRK2. Interacts with NEMP1 and KPNB1 (By
CC       similarity). {ECO:0000250|UniProtKB:P62827,
CC       ECO:0000269|PubMed:10209022, ECO:0000269|PubMed:10400640,
CC       ECO:0000269|PubMed:11425870, ECO:0000269|PubMed:11571268,
CC       ECO:0000269|PubMed:12808100, ECO:0000269|PubMed:14500717,
CC       ECO:0000269|PubMed:14612415, ECO:0000269|PubMed:14684163,
CC       ECO:0000269|PubMed:15574331, ECO:0000269|PubMed:18591255,
CC       ECO:0000269|PubMed:18617507, ECO:0000269|PubMed:1961752,
CC       ECO:0000269|PubMed:19753112, ECO:0000269|PubMed:9323133,
CC       ECO:0000269|PubMed:9837918}.
CC   -!- INTERACTION:
CC       O15392:BIRC5; NbExp=7; IntAct=EBI-286642, EBI-518823;
CC       O94829:IPO13; NbExp=13; IntAct=EBI-286642, EBI-747310;
CC       P61970:NUTF2; NbExp=3; IntAct=EBI-286642, EBI-591778;
CC       P18754:RCC1; NbExp=6; IntAct=EBI-286642, EBI-992720;
CC       Q92973:TNPO1; NbExp=2; IntAct=EBI-286642, EBI-286693;
CC       Q99986:VRK1; NbExp=12; IntAct=EBI-286642, EBI-1769146;
CC       Q86Y07-1:VRK2; NbExp=2; IntAct=EBI-286642, EBI-1207633;
CC       Q86Y07-5:VRK2; NbExp=2; IntAct=EBI-286642, EBI-1207649;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Melanosome. Nucleus
CC       envelope {ECO:0000250|UniProtKB:P62827}. Note=Predominantly
CC       nuclear during interphase. Becomes dispersed throughout the
CC       cytoplasm during mitosis. Colocalizes with NEMP1 at the nuclear
CC       envelope (By similarity). Identified by mass spectrometry in
CC       melanosome fractions from stage I to stage IV.
CC       {ECO:0000250|UniProtKB:P62827}.
CC   -!- TISSUE SPECIFICITY: Expressed in a variety of tissues.
CC       {ECO:0000269|PubMed:2108320}.
CC   -!- SIMILARITY: Belongs to the small GTPase superfamily. Ran family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB93486.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RANID4203912q24.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M31469; AAA36546.1; -; mRNA.
DR   EMBL; AF052578; AAC05840.1; -; mRNA.
DR   EMBL; AF054183; AAC99400.1; -; mRNA.
DR   EMBL; AF501887; AAM15923.1; -; mRNA.
DR   EMBL; BT007271; AAP35935.1; -; mRNA.
DR   EMBL; CR450347; CAG29343.1; -; mRNA.
DR   EMBL; AK290763; BAF83452.1; -; mRNA.
DR   EMBL; AK312466; BAG35373.1; -; mRNA.
DR   EMBL; CH471054; EAW98516.1; -; Genomic_DNA.
DR   EMBL; BC004272; AAH04272.3; -; mRNA.
DR   EMBL; BC014518; AAH14518.1; -; mRNA.
DR   EMBL; BC014901; AAH14901.1; -; mRNA.
DR   EMBL; BC016654; AAH16654.1; -; mRNA.
DR   EMBL; BC051908; AAH51908.2; -; mRNA.
DR   EMBL; BC072000; AAH72000.1; -; mRNA.
DR   EMBL; AB062399; BAB93486.1; ALT_INIT; mRNA.
DR   CCDS; CCDS9271.1; -.
DR   PIR; A44393; TVHUC3.
DR   RefSeq; NP_001287725.1; NM_001300796.1.
DR   RefSeq; NP_001287726.1; NM_001300797.1.
DR   RefSeq; NP_006316.1; NM_006325.4.
DR   UniGene; Hs.10842; -.
DR   PDB; 1I2M; X-ray; 1.76 A; A/C=1-216.
DR   PDB; 1IBR; X-ray; 2.30 A; A/C=1-216.
DR   PDB; 1K5D; X-ray; 2.70 A; A/D/G/J=1-216.
DR   PDB; 1K5G; X-ray; 3.10 A; A/D/G/J=1-216.
DR   PDB; 1QBK; X-ray; 3.00 A; C=1-216.
DR   PDB; 1RRP; X-ray; 2.96 A; A/C=8-211.
DR   PDB; 2MMC; NMR; -; A=1-216.
DR   PDB; 2MMG; NMR; -; A=1-216.
DR   PDB; 3CH5; X-ray; 2.10 A; A=1-216.
DR   PDB; 3EA5; X-ray; 2.50 A; A/C=1-216.
DR   PDB; 3GJ0; X-ray; 1.48 A; A/B=2-216.
DR   PDB; 3GJ3; X-ray; 1.79 A; A=2-216.
DR   PDB; 3GJ4; X-ray; 2.15 A; A/C=2-216.
DR   PDB; 3GJ5; X-ray; 1.79 A; A/C=2-216.
DR   PDB; 3GJ6; X-ray; 2.70 A; A=2-216.
DR   PDB; 3GJ7; X-ray; 1.93 A; A/C=2-216.
DR   PDB; 3GJ8; X-ray; 1.82 A; A/C=2-216.
DR   PDB; 3GJX; X-ray; 2.50 A; C/F=1-216.
DR   PDB; 3NBY; X-ray; 3.42 A; C/F=5-180.
DR   PDB; 3NBZ; X-ray; 2.80 A; C/F=5-180.
DR   PDB; 3NC0; X-ray; 2.90 A; C/F=5-180.
DR   PDB; 3NC1; X-ray; 3.35 A; C=1-180.
DR   PDB; 3ZJY; X-ray; 3.60 A; A/D/F=1-180.
DR   PDB; 4C0Q; X-ray; 3.42 A; C/D=2-216.
DR   PDB; 4GMX; X-ray; 2.10 A; A=1-216.
DR   PDB; 4GPT; X-ray; 2.22 A; A=1-216.
DR   PDB; 4HAT; X-ray; 1.78 A; A=1-216.
DR   PDB; 4HAU; X-ray; 2.00 A; A=1-216.
DR   PDB; 4HAV; X-ray; 2.00 A; A=1-216.
DR   PDB; 4HAW; X-ray; 1.90 A; A=1-216.
DR   PDB; 4HAX; X-ray; 2.28 A; A=1-216.
DR   PDB; 4HAY; X-ray; 2.30 A; A=1-216.
DR   PDB; 4HAZ; X-ray; 1.90 A; A=1-216.
DR   PDB; 4HB0; X-ray; 2.20 A; A=1-216.
DR   PDB; 4HB2; X-ray; 1.80 A; A=1-216.
DR   PDB; 4HB3; X-ray; 2.80 A; A=1-216.
DR   PDB; 4HB4; X-ray; 2.05 A; A=1-216.
DR   PDB; 4OL0; X-ray; 2.90 A; A=1-216.
DR   PDBsum; 1I2M; -.
DR   PDBsum; 1IBR; -.
DR   PDBsum; 1K5D; -.
DR   PDBsum; 1K5G; -.
DR   PDBsum; 1QBK; -.
DR   PDBsum; 1RRP; -.
DR   PDBsum; 2MMC; -.
DR   PDBsum; 2MMG; -.
DR   PDBsum; 3CH5; -.
DR   PDBsum; 3EA5; -.
DR   PDBsum; 3GJ0; -.
DR   PDBsum; 3GJ3; -.
DR   PDBsum; 3GJ4; -.
DR   PDBsum; 3GJ5; -.
DR   PDBsum; 3GJ6; -.
DR   PDBsum; 3GJ7; -.
DR   PDBsum; 3GJ8; -.
DR   PDBsum; 3GJX; -.
DR   PDBsum; 3NBY; -.
DR   PDBsum; 3NBZ; -.
DR   PDBsum; 3NC0; -.
DR   PDBsum; 3NC1; -.
DR   PDBsum; 3ZJY; -.
DR   PDBsum; 4C0Q; -.
DR   PDBsum; 4GMX; -.
DR   PDBsum; 4GPT; -.
DR   PDBsum; 4HAT; -.
DR   PDBsum; 4HAU; -.
DR   PDBsum; 4HAV; -.
DR   PDBsum; 4HAW; -.
DR   PDBsum; 4HAX; -.
DR   PDBsum; 4HAY; -.
DR   PDBsum; 4HAZ; -.
DR   PDBsum; 4HB0; -.
DR   PDBsum; 4HB2; -.
DR   PDBsum; 4HB3; -.
DR   PDBsum; 4HB4; -.
DR   PDBsum; 4OL0; -.
DR   ProteinModelPortal; P62826; -.
DR   SMR; P62826; 8-216.
DR   BioGrid; 111837; 107.
DR   DIP; DIP-5929N; -.
DR   IntAct; P62826; 47.
DR   MINT; MINT-94188; -.
DR   STRING; 9606.ENSP00000376176; -.
DR   TCDB; 9.A.60.1.1; the small nuclear rna exporter (snrna-e).
DR   PhosphoSite; P62826; -.
DR   BioMuta; RAN; -.
DR   DMDM; 51338598; -.
DR   OGP; P62826; -.
DR   REPRODUCTION-2DPAGE; P62826; -.
DR   UCD-2DPAGE; P62826; -.
DR   MaxQB; P62826; -.
DR   PaxDb; P62826; -.
DR   PRIDE; P62826; -.
DR   DNASU; 5901; -.
DR   Ensembl; ENST00000392369; ENSP00000376176; ENSG00000132341.
DR   Ensembl; ENST00000543796; ENSP00000446215; ENSG00000132341.
DR   GeneID; 5901; -.
DR   KEGG; hsa:5901; -.
DR   UCSC; uc001uir.3; human.
DR   CTD; 5901; -.
DR   GeneCards; GC12P131356; -.
DR   HGNC; HGNC:9846; RAN.
DR   MIM; 601179; gene.
DR   neXtProt; NX_P62826; -.
DR   PharmGKB; PA34205; -.
DR   eggNOG; COG1100; -.
DR   GeneTree; ENSGT00750000117729; -.
DR   HOVERGEN; HBG107376; -.
DR   InParanoid; P62826; -.
DR   KO; K07936; -.
DR   OrthoDB; EOG7C8GJ1; -.
DR   PhylomeDB; P62826; -.
DR   TreeFam; TF106302; -.
DR   Reactome; REACT_12417; MicroRNA (miRNA) biogenesis.
DR   Reactome; REACT_147797; Regulation of cholesterol biosynthesis by SREBP (SREBF).
DR   Reactome; REACT_268530; Transcriptional regulation by small RNAs.
DR   Reactome; REACT_6179; NEP/NS2 Interacts with the Cellular Export Machinery.
DR   Reactome; REACT_6190; Rev-mediated nuclear export of HIV RNA.
DR   Reactome; REACT_9395; Nuclear import of Rev protein.
DR   SignaLink; P62826; -.
DR   ChiTaRS; RAN; human.
DR   EvolutionaryTrace; P62826; -.
DR   GeneWiki; Ran_(biology); -.
DR   GenomeRNAi; 5901; -.
DR   NextBio; 22956; -.
DR   PRO; PR:P62826; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; P62826; -.
DR   ExpressionAtlas; P62826; baseline and differential.
DR   Genevisible; P62826; HS.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0005643; C:nuclear pore; NAS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0042565; C:RNA nuclear export complex; IDA:BHF-UCL.
DR   GO; GO:0050681; F:androgen receptor binding; NAS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; TAS:UniProtKB.
DR   GO; GO:0019003; F:GDP binding; IMP:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IDA:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; TAS:UniProtKB.
DR   GO; GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; NAS:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0034629; P:cellular protein complex localization; IEA:Ensembl.
DR   GO; GO:0006259; P:DNA metabolic process; TAS:UniProtKB.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0007067; P:mitotic nuclear division; TAS:UniProtKB.
DR   GO; GO:0007052; P:mitotic spindle organization; TAS:UniProtKB.
DR   GO; GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0035281; P:pre-miRNA export from nucleus; IC:BHF-UCL.
DR   GO; GO:0006611; P:protein export from nucleus; IDA:BHF-UCL.
DR   GO; GO:0006606; P:protein import into nucleus; IBA:GO_Central.
DR   GO; GO:0000060; P:protein import into nucleus, translocation; IMP:UniProtKB.
DR   GO; GO:1902570; P:protein localization to nucleolus; IMP:UniProtKB.
DR   GO; GO:0000055; P:ribosomal large subunit export from nucleus; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0000056; P:ribosomal small subunit export from nucleus; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0007165; P:signal transduction; TAS:UniProtKB.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0019058; P:viral life cycle; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; TAS:Reactome.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR002041; Ran_GTPase.
DR   InterPro; IPR005225; Small_GTP-bd_dom.
DR   InterPro; IPR001806; Small_GTPase.
DR   Pfam; PF00071; Ras; 1.
DR   PRINTS; PR00627; GTPRANTC4.
DR   SMART; SM00176; RAN; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00231; small_GTP; 1.
DR   PROSITE; PS51418; RAN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell cycle; Cell division;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; GTP-binding;
KW   Host-virus interaction; Isopeptide bond; Mitosis; Nucleotide-binding;
KW   Nucleus; Polymorphism; Protein transport; Reference proteome;
KW   Transport; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:19413330,
FT                                ECO:0000269|PubMed:22223895,
FT                                ECO:0000269|PubMed:22814378,
FT                                ECO:0000269|Ref.12}.
FT   CHAIN         2    216       GTP-binding nuclear protein Ran.
FT                                /FTId=PRO_0000208696.
FT   NP_BIND      17     24       GTP. {ECO:0000250}.
FT   NP_BIND      65     69       GTP. {ECO:0000250}.
FT   NP_BIND     122    125       GTP. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000269|PubMed:19413330,
FT                                ECO:0000269|PubMed:22223895,
FT                                ECO:0000269|PubMed:22814378,
FT                                ECO:0000269|Ref.12}.
FT   MOD_RES      60     60       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19608861}.
FT   MOD_RES      71     71       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:19608861}.
FT   MOD_RES      99     99       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19608861}.
FT   MOD_RES     159    159       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:19608861}.
FT   MOD_RES     159    159       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P62827}.
FT   CROSSLNK     71     71       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin);
FT                                alternate.
FT   VARIANT      95     95       R -> I (in dbSNP:rs11546488).
FT                                /FTId=VAR_051900.
FT   MUTAGEN      19     19       G->V: Blocks DNA replication; when
FT                                associated with L-69.
FT                                {ECO:0000269|PubMed:8421051}.
FT   MUTAGEN      24     24       T->L: Has low binding affinity for GTP
FT                                and GDP. Almost completely abolishes
FT                                interaction with BIRC5.
FT                                {ECO:0000269|PubMed:18591255}.
FT   MUTAGEN      69     69       Q->L: Blocks DNA replication; when
FT                                associated with V-19.
FT                                {ECO:0000269|PubMed:18591255,
FT                                ECO:0000269|PubMed:8421051}.
FT   MUTAGEN      69     69       Q->N: Unable to hydrolyze GTP. Increases
FT                                binding to BIRC5 and promotes exaggerated
FT                                spindle formation.
FT                                {ECO:0000269|PubMed:18591255,
FT                                ECO:0000269|PubMed:8421051}.
FT   CONFLICT      2      2       A -> T (in Ref. 11; AAH72000).
FT                                {ECO:0000305}.
FT   CONFLICT    181    181       A -> C (in Ref. 5; AAC99400).
FT                                {ECO:0000305}.
FT   TURN          2      5       {ECO:0000244|PDB:2MMG}.
FT   STRAND       10     17       {ECO:0000244|PDB:3GJ0}.
FT   STRAND       18     22       {ECO:0000244|PDB:1QBK}.
FT   HELIX        23     27       {ECO:0000244|PDB:3GJ0}.
FT   HELIX        31     35       {ECO:0000244|PDB:3GJ0}.
FT   STRAND       38     40       {ECO:0000244|PDB:3GJ0}.
FT   TURN         41     44       {ECO:0000244|PDB:3GJ0}.
FT   STRAND       45     54       {ECO:0000244|PDB:3GJ0}.
FT   STRAND       57     66       {ECO:0000244|PDB:3GJ0}.
FT   HELIX        69     71       {ECO:0000244|PDB:3GJ0}.
FT   HELIX        74     76       {ECO:0000244|PDB:1K5D}.
FT   HELIX        77     80       {ECO:0000244|PDB:3GJ0}.
FT   STRAND       85     91       {ECO:0000244|PDB:3GJ0}.
FT   STRAND       92     94       {ECO:0000244|PDB:1RRP}.
FT   HELIX        95     99       {ECO:0000244|PDB:3GJ0}.
FT   HELIX       101    111       {ECO:0000244|PDB:3GJ0}.
FT   STRAND      112    114       {ECO:0000244|PDB:3NBZ}.
FT   STRAND      117    122       {ECO:0000244|PDB:3GJ0}.
FT   STRAND      126    128       {ECO:0000244|PDB:3GJ0}.
FT   HELIX       133    135       {ECO:0000244|PDB:3GJ0}.
FT   HELIX       138    142       {ECO:0000244|PDB:3GJ0}.
FT   STRAND      145    148       {ECO:0000244|PDB:3GJ0}.
FT   TURN        151    154       {ECO:0000244|PDB:3GJ0}.
FT   TURN        156    158       {ECO:0000244|PDB:3GJ0}.
FT   HELIX       159    169       {ECO:0000244|PDB:3GJ0}.
FT   STRAND      176    178       {ECO:0000244|PDB:3GJ0}.
FT   TURN        185    187       {ECO:0000244|PDB:1QBK}.
FT   HELIX       191    205       {ECO:0000244|PDB:3GJ0}.
FT   HELIX       211    215       {ECO:0000244|PDB:2MMC}.
SQ   SEQUENCE   216 AA;  24423 MW;  D5C9B7275C34BCE0 CRC64;
     MAAQGEPQVQ FKLVLVGDGG TGKTTFVKRH LTGEFEKKYV ATLGVEVHPL VFHTNRGPIK
     FNVWDTAGQE KFGGLRDGYY IQAQCAIIMF DVTSRVTYKN VPNWHRDLVR VCENIPIVLC
     GNKVDIKDRK VKAKSIVFHR KKNLQYYDIS AKSNYNFEKP FLWLARKLIG DPNLEFVAMP
     ALAPPEVVMD PALAAQYEHD LEVAQTTALP DEDDDL
//
